[tdc_zone][vc_row][vc_column]
[/vc_column][/vc_row][vc_row full_width=””][vc_column]
[/vc_column][/vc_row][vc_row el_class=”td-ss-row”][vc_column width=”2/3″][vc_raw_html]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[/vc_raw_html]
Most Popular Blog Posts
MRI-Guided TULSA Shows Efficacy in Prostate Cancer
MRI-guided transurethral ultrasound ablation can be performed on an outpatient basis, is noninvasive, has low side effects and, in the TACT trial, induced substantial reductions in PSA levels. Medscape Medical News
Certain Anerobic Bacteria Linked to Increased CRC Risk
Certain anerobic bacteria have been linked with a dramatically increased risk for colorectal cancer, often within a year of infection, but whether they actually cause CRC has yet to be determined. Medscape Medical News
Metformin, Testosterone Replacement Linked to Reduced Cancer Risk
The use of the diabetes drug and testosterone replacement therapy, independently and in combination, were linked to reductions in the incidence of prostate and colorectal cancers. Medscape Medical News
Update on Follicular Lymphoma Webinar – March 17, 2022
Webinars
setREVStartSize({c: 'rev_slider_87_2',rl:,el:,gw:,gh:,type:'hero',justify:'',layout:'fullwidth',mh:"320"});
var revapi87,
tpj;
function revinit_revslider872() {
jQuery(function() {
tpj = jQuery;
revapi87 = tpj("#rev_slider_87_2");
if(revapi87==undefined || revapi87.revolution == undefined){
revslider_showDoubleJqueryError("rev_slider_87_2");
}else{
revapi87.revolution({
sliderType:"hero",
sliderLayout:"fullwidth",
visibilityLevels:",1184,980,767",
gridwidth:"1170,970,750,320",
gridheight:"320,320,226,94",
minHeight:320,
spinner:"spinner0",
perspective:600,
perspectiveType:"local",
editorheight:"320,320,226,94",
responsiveLevels:",1184,980,767",
progressBar:{disableProgressBar:true},
navigation: {
onHoverStop:false
},
fallbacks: {
allowHTML5AutoPlayOnAndroid:true
},
});
}
});
} // End of RevInitScript
var once_revslider872 = false;
if (document.readyState === "loading") {document.addEventListener('readystatechange',function() { if((document.readyState === "interactive" || document.readyState === "complete") && !once_revslider872 ) { once_revslider872 = true; revinit_revslider872();}});} else {once_revslider872 =...
PTSD Linked to Increased Risk of Ovarian Cancer
Women who exhibit many classic symptoms of post-traumatic stress disorder (PTSD) may be much more likely to develop ovarian cancer than their counterparts who don't, a new study suggests. Reuters Health Information
Precision Medicine
Virtual Tumor Board Faster and Better Than Real Life
A virtual molecular tumor board platform reduced case-review times from 14 days to 4 days. Researchers hope that the cloud-based platform could extend precision medicine to all cancer patients in the US. Medscape Medical News
Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
From genes to genomes and genomics
The concept of precision oncology is not exactly a new one. Since the development of hormonal therapies for breast cancer 40 years ago,1 their efficacy was determined based on the predictive value of specific hormone receptor expression patterns. The development of specific targeted therapies, including trastuzumab for breast cancer2 or...
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
By Khalid El Bairi, MDOn a beautiful morning in early October 2022, I received a WhatsApp message from an enthusiastic young professor of pharmacy, Dr. Faisal Gulzar, who invited me to deliver presentations in a country very far from my home in Morocco—Pakistan! A country that I've never visited and that I mostly know...
Ai in oncology
AI Holds Its Own vs Pathologists for Prostate Cancer Diagnosis
Artificial intelligence (AI) performs as well as expert uropathologists in diagnosing and grading prostate cancer, suggests a new study. Medscape Medical News
ACTRIMS Forum to Focus on Precision Medicine in MS
DALLAS — The fourth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2019 gets underway this week in Dallas, Texas, with a packed agenda focused on advancing the understanding of MS diagnosis and management.
With an expected attendance of more than 1000, the ACTRIMS Forum sets itself apart from other medical...
AI System Improves Early Gastric Cancer Detection
An artificial intelligence system was effective for real-time monitoring of endoscopic "blind spots" and improved detection of early gastric cancer during esophagogastroduodenoscopy. Medscape Medical News
LATEST ARTICLES
Changing The Narrative: 10 Recommendations for Caring for Young Adults With Lung Cancer
By Narjust Florez, MD, Fatima Wilder, MD, MSc, Lauren Kiel, BS, and Rebekah Kaufman, MSIt is about time that we change the narrative of lung cancer being a disease that impacts elderly men with a smoking history into one that encompasses our modern reality of an inclusive patient population, including women and especially including...
Erin Parry, MD, PhD
Researcher Spotlight
Home » Erin Parry, MD, PhD
Researcher Spotlight: Erin Parry, MD, PhD
DANA-FARBER CANCER INSTITUTE
Dr. Parry’s research is centered at the intersection of genomics and cancer immunotherapy, with a focus on B cell lymphomas. Her LRF research project is aimed at understanding...
Wen-Hsuan Wendy Lin, MD, PhD
Researcher Spotlight
Home » Wen-Hsuan Wendy Lin, MD, PhD
Researcher Spotlight: Wen-Hsuan Wendy Lin, MD, PhD
COLUMBIA UNIVERSITY
Peripheral T-cell lymphomas (PTCL) represent a group of aggressive blood cancers with poor outcomes. A common phenomenon in PTCL is the development of a proinflammatory microenvironment, in...
Andrew Jallouk, MD, PhD
Researcher Spotlight
Home » Andrew Jallouk, MD, PhD
Researcher Spotlight: Andrew Jallouk, MD, PhD
VANDERBILT UNIVERSITY MEDICAL CENTER
Errol M. Cook Memorial Scholar
Chimeric antigen receptor (CAR) T-cell therapy represents a highly effective treatment option for many types of lymphoma. Currently available CAR T-cell therapies are...
Alexander Boardman, MD
Researcher Spotlight
Home » Alexander Boardman, MD
Researcher Spotlight: Alexander Boardman, MD
MEMORIAL SLOAN KETTERING
Dobosh Family Scholar
Treatment of lymphoma has been revolutionized by the emergence of CD19-directed chimeric antigen receptor (CAR) T-cell therapies, but many patients still relapse after treatment. Dr. Boardman’s LRF research...
